chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a pharmacist concerning her sister-in-law, a female with asthma who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation).  Subsequently, the patient experienced difficulty in breathing.  The patient sought unspecified medical attention.  No further information is available.
p/vax mom reported pt devel a rash around mouth, swelling & welts to eyes & eyelids, sl inc in cough
A report has been received from a Health Professional concerning, a male subject, who had been receiving Nasal FLUMIST (intranasal), 0.1 Millilitres, Unknown FLUMIST (intranasal) started on 28-Oct-2015. Patient was administered only half the FLUMIST dose 0.1mL) because child was uncooperative and so the second dose in the second nostril was not even attempted to be administered. The outcome of the event of WRONG DOSE GIVEN was unknown. The reporter's description of the event (s) was as follows: has received Flu vaccine (IM) previously. The report was considered to be non-serious. The reporter considered that there was no causal relationship between WRONG DOSE GIVEN and FLUMIST.
She completed Pfizer COVID vaccines on 3/27/21. She was tested positive with COVID on 8/28/21. She went to the local urgent care due to worsening cough, SOB, body aches, and nausea, and she was transferred to Hospital, and admiited for further treatment. Hospital on 9/1/21. Hospital day 3: She is on O2 2L and receiving Remdesivir and Dexamethasone.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 01-APR-2015,  the patient was vaccinated with ZOSTAVAX as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, anatomical location, lot#, expiration date were unknown). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles (onset date was not provided). On 01-SEP-2015, the patient was treated in emergency room for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The events were reported as related to the therapy with ZOSTAVAX.
pt recvd 2nd dose of Recombivax mentioned had numbness & tingling in hand & fingers for 2 hrs; p/1st inject called MD who said not to given 2nd inject p/consulting w/pharmacist; no nausea, itching or hives;
arthritis; inflammation; interstitial cystitis, been dormant since 2009 but kicked in now; fever; body aches; headache everyday; Missed second dose; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (arthritis), INFLAMMATION (inflammation), CYSTITIS INTERSTITIAL (interstitial cystitis, been dormant since 2009 but kicked in now), PYREXIA (fever) and MYALGIA (body aches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (arthritis), INFLAMMATION (inflammation), CYSTITIS INTERSTITIAL (interstitial cystitis, been dormant since 2009 but kicked in now), PYREXIA (fever), MYALGIA (body aches), HEADACHE (headache everyday) and PRODUCT DOSE OMISSION ISSUE (Missed second dose). At the time of the report, ARTHRITIS (arthritis), INFLAMMATION (inflammation), CYSTITIS INTERSTITIAL (interstitial cystitis, been dormant since 2009 but kicked in now), PYREXIA (fever), MYALGIA (body aches), HEADACHE (headache everyday) and PRODUCT DOSE OMISSION ISSUE (Missed second dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No concomitant medications were reported. No treatment medications were reported.  This spontaneous case concerning a 72-year-old, female patient with no medical history, who experienced unexpected adverse events of Arthritis, Inflammation, Cystitis interstitial, and expected non serious events of Pyrexia, Myalgia and Headache after the first dose of mRNA-1273 vaccine administration. Due to reported events patient decided not to take second dose of mRNA-1273. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report; Sender's Comments: This spontaneous case concerning a 72-year-old, female patient with no medical history, who experienced unexpected adverse events of Arthritis, Inflammation, Cystitis interstitial, and expected non serious events of Pyrexia, Myalgia and Headache after the first dose of mRNA-1273 vaccine administration. Due to reported events patient decided not to take second dose of mRNA-1273. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report
The outcome is permanet Restricted Breathing - Cannot Do Treadmill Anymore - Have gained WT since.
Throat tightness; I had to keep clearing my throat to make my self comfortable; Itchy; Covid arm; Diffuse rashes over arm; Red; This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Throat tightness), SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable), PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm) and RASH (Diffuse rashes over arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007MZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced THROAT TIGHTNESS (Throat tightness), SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable), PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm), RASH (Diffuse rashes over arm) and INJECTION SITE ERYTHEMA (Red). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at a dose of Unknown and DIPHENHYDRAMINE at a dose of Unknown. On 20-Feb-2021, PRURITUS (Itchy), INJECTION SITE REACTION (Covid arm), RASH (Diffuse rashes over arm) and INJECTION SITE ERYTHEMA (Red) had resolved. On 16-Mar-2021, THROAT TIGHTNESS (Throat tightness) and SENSATION OF FOREIGN BODY (I had to keep clearing my throat to make my self comfortable) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Medical history and Concomitants were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Follow-up received on 29-03-2021 updated events and anatomy location . Events are red, delayed reaction, at the same time had throat tightness. On 05-Aug-2021: Follow up received contains No New Information. On 05-Aug-2021: Follow up received contains No New Information
Shaky; really bad headache; exhausted; severe stomach pain, like stabbing pain, aching at first; a lot of discomfort; soreness at the injection point; Nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (severe stomach pain, like stabbing pain, aching at first), NERVOUSNESS (Shaky), DISCOMFORT (a lot of discomfort), VACCINATION SITE PAIN (soreness at the injection point) and NAUSEA (Nausea) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (severe stomach pain, like stabbing pain, aching at first), DISCOMFORT (a lot of discomfort), VACCINATION SITE PAIN (soreness at the injection point), NAUSEA (Nausea) and VOMITING (vomiting). On 09-Mar-2021, the patient experienced FATIGUE (exhausted). On 10-Mar-2021, the patient experienced NERVOUSNESS (Shaky) and HEADACHE (really bad headache). On 11-Mar-2021, ABDOMINAL PAIN UPPER (severe stomach pain, like stabbing pain, aching at first), NERVOUSNESS (Shaky), DISCOMFORT (a lot of discomfort), VACCINATION SITE PAIN (soreness at the injection point), NAUSEA (Nausea), VOMITING (vomiting), FATIGUE (exhausted) and HEADACHE (really bad headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was given. No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Additional information received on 06-May-2021 added contact information
On 12/21/10, 67 yo F presented to clinic. During this visit, patient was given Tdap & pneumonia vaccinations. Per patient request, vaccines were both given in left upper arm. On 12/22, patient developed significant pain & induration at injection sites. Patient went to ED & was started on cephalexin 500 mg PO QID, Septra & Vicodin. On 12/23, patient's symptoms persisted with worsened pain, swelling, & erythema. Patient was en route to ED & developed chest pain. Patient was admitted & started on vancomycin. During hospitalization, patient's symptoms improved & chest pain was determined to be non-cardiac in nature. On 12/28, pt d/c'd home & continued on oral doxycycline & clindamycin. On 01/04/11, patient returned to clinic. At that time, some erythema persisted. Patient was prescribed another course of unknown oral antibiotics. Pt remains under treament.
Patient vaccinated, ambulated to flow staff to check vaccination card information, appeared flush signaled for NP to assist NP assessed patient, lowered to ground, then assisted to chair, NP reported to side A, patient alert, awake, communicating with staff, and diaphoretic. Patient transported via wheelchair to observation area: EMS, NP, and observation staff assist.  EMS leads applied VSS obtained HR 62, BP 94/57, temp97.2 F, blood glucose 108, patient stable cold pack applied, requesting a drink.   0853 patient reports not eating breakfast, snack and additional fluids given, VSS. Patient stable in observation refused to notify parent or emergency contact, emergency contact obtained mother notified of incident.  0922 VSS, refuse transport to higher level of care, patient denies concerns, discharged from vaccine site in stable condition.,
Extremely heavy menstruar cycle although wasn?t meant to get period as I never stopped taking the pills, also two weeks later I still have spotting and usual period time is 5 days. First time I?ve had an irregular menstrual cycle in my life
Initial pain and fever on 8/7/2021. Pain in left arm turned into numbness. Numbness extended down the arm and severe headaches persisted. Weakness in muscles including legs developed after about 5-6 days. Overall, extreme exhaustion and weakness after the first week. Chest pain developed.  On 8/18, numbness on the left side of my face appeared. All other symptoms previously noted were present.
Within 30 minutes patient developed nickle-sized red bump. By next day it was the size of a 50 cent piece. The next day if was larger and warm and sore to touch. She also had a low-grade fever. Visited family doctor on 9/25/14 and was diagnosed with local cellulitis and prescribed Augmentin 875mg twice a day for 10 days. By 9/27/14 the bump was resolving but not yet gone.
I have tested positive for Covid; I have tested positive for Covid; This is a spontaneous report from a contactable consumer (patient) from a 76-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number unknown, Expiration date unknown), via an unspecified route of administration, on 02Mar2021at single dose for Covid-19 immunization. The patient medical history and concomitant medication were not reported. On 15thMar2021, the patient tested positive for COVID-19 and is being quarantined for 10 days. The outcome of event was unknown.  Information on lot/ batch has been requested.
felt hot after shot; inside left leg had water blisters; eight sites with welts; very red; in much pain on left side; skin is tight; skin hurts; This spontaneous case was reported by a patient and describes the occurrence of FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red) and PAIN (in much pain on left side) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red), PAIN (in much pain on left side), SKIN TIGHTNESS (skin is tight) and PAIN OF SKIN (skin hurts). At the time of the report, FEELING HOT (felt hot after shot), BLISTER (inside left leg had water blisters), URTICARIA (eight sites with welts), ERYTHEMA (very red), PAIN (in much pain on left side), SKIN TIGHTNESS (skin is tight) and PAIN OF SKIN (skin hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
After my 4th shot on September 9, 2022, about 12 hours after I started to get symptoms of swelling under my left arm which was the same side as my injection. I also experienced breast pain on that same side.  The general swelling lasted a couple days, but the pain in my breast lasted about 3 weeks, started to get better but occasionally still comes and goes.  I feel general aches around the side of my breast and even near my rib case. However I have not had any swelling return.
Dizzy; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: EK4176) intramuscularly in the left upper arm on 13Jan2021 at 14:45 (at the age of 27-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were reported as none. The patient did not receive any other vaccines within 4 weeks of the vaccination. On 13Jan2021, the patient was dizzy to the point of needing to lay down. The patient queried whether she should take the second dose. The patient did not receive treatment for this event, nor did the event require a visit to the emergency room or doctor's office. The clinical outcome of "dizzy" was resolved on 24Jan2021.
hot circle; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot circle) and VACCINATION SITE ERYTHEMA (red) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Don't have that with her) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot circle) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE WARMTH (hot circle) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
9/15 evening very painful (R) arm/shoulder - pain extended down toward elbow. Difficulty with full ROM secondary pain. Improved next day, continued slow improvement - still with pain (R) shoulder when reaches (R) arm across body.
This spontaneous report as received from a physician refers to multiple patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant medications were not reported.  On unknown dates, the patients were vaccinated with an unspecified number of doses of improperly stored VARIVAX injection, 0.5 ml, subcutaneously, lot# M027343 with expiration date: 01-JUN-2018. Administered doses of VARIVAX were exposed to the temperature of 8.6 Fahrenheit degrees for 25 hours. Data logger was involved. There were no previous excursions. No adverse effects were reported. Product quality complaint (PQC) was not involved. Follow up information was received on 05-DEC-2016. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.; Sender's Comments: ,MERCK 1610USA009201:Mfr number.
Left arm swollen with 2" x 1", hot to touch, hardness and pain. Advised Benadryl, Tylenol and cold compresses.
This spontaneous report as received from a nurse practitioner (N. P), refers to a patient of an unknown age and gender. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (Lot # not reported) (dose and route not reported). Concomitant therapy was not reported. On an unspecified date, the patient was on Prednisone (dosages and manufacturer unspecified) because of rash on both arms that developed after she received ZOSTAVAX. The outcome of rash on both arms was unknown. This case is related with  MARRS 1309USA000504. Additional information has been requested.
I woke up the next morning with aches/chills/fever like symptoms which I knew was probably a side effect of the flu vaccine. Throughout the day my symptoms got worse, specifically muscle soreness and aches, until I could not drive myself to an after school event and had to have a friend drive me because the muscles in my legs were so tight. I  had severe cramps and muscle pains all up and down my legs. I did not go back to my doctor because I knew it was an adverse reaction to the vaccine and would pass, especially because this was the first time I have had the flu vaccine since I was a child.
Brain Bleed.; Pain in back of neck; BNT162B2 in right leg; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8727, expiration date not provided), via an unspecified route of administration, in right leg, on 26Mar2021 17:45 (at the age of 63-year-old), at single dose, for COVID-19 immunization. Medical history included high blood pressure. Patient had no known allergies. No COVID prior vaccination. No other vaccine in four weeks. Concomitant medications included paracetamol (TYLENOL), ibuprofen (ADVIL). The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EV6206, expiration date not provided), via an unspecified route of administration, in right arm, on 03Mar2021 17:45  (at the age of 63-year-old), at single dose, for COVID-19 immunization. On 27Mar2021 03:30, the patient experienced pain in back of neck and brain bleed. Events resulted in emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event), disability or permanent damage. Patient was hospitalized for 19 days. The patient underwent lab tests and procedures, which included COVID test was negative in Apr2021. Therapeutic measures were taken as a result of events and included treatment with observation intensive care unit (ICU) 7 days, tube feed and medication. The outcome of the events "pain in back of neck and brain bleed" was not recovered.
patient did not disclose that he had received 2 previous pfizer vaccines at the time of vaccination.  when called at home after the fact, he remembered he had received it.
Information has been received from a Registered Nurse concerning a 13 year old white male with unknown medical history and no known drug allergies who on 22-JAN-1997 was vaccinated with a first dose of VARIVAX (Oka/Merck) (Lot # not available).  On 17-NOV-2008 the patient developed 10 papular and vesicular areas on lower abdomen and right side of chest during 4 days and was diagnosed of VARICELLA by the Doctor.  It was reported that his brother had VARICELLA 1 1/2 week ago.  In December 2008 the patient was recovered.  Additional information is not expected.
Fever, balance difficulties, irritability, and fatigue.  Gave acetaminophen for fever, fever (100.0) went down to 99.1 after.
was given the first dose approx. 2 moths ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (was given the first dose approx. 2 moths ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (was given the first dose approx. 2 moths ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (was given the first dose approx. 2 moths ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. The patient wanted to know what to do. No treatment medications were provided.  Company Comment: This report refers to a case of Product dose omission for mRNA-1273 in an immunosuppressed patient, with no adverse events.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of Product dose omission for mRNA-1273 in an immunosuppressed patient, with no adverse events.
Received vaccine at approximately 10:00 a.m. 11/02/09.  At 6:00 a.m. 11/03/09 noticed blisters all around her mouth that worsened over the next two days.  Did not see a physician.  She spoke with pharmacist who told her to take Valtrex.  She stated that the Valtrex did not help any.
mild arm soreness; This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer and shingles.   In May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The reporter was a retired nurse. The patient received Shingrix and had mild arm soreness. It resolved quickly. The reporter consented to follow up. This case linked with US2020180914 and US2020AMR181528, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020180914:same reporter US-GLAXOSMITHKLINE-US2020AMR181528:same reporter
Patient received the vaccine Thursday 4/8/21 and on the Friday went to Hospital in complaining of not being able to breathe.  A chest x-ray was done to rule out a PE.  None was found.  The following day the patient was called back and found to have a blood clot in her left calf muscle.  She was treated and is now ok. I do not know specific test and dates. Hospital was the treatment facility.  Patient did not know the name of the Doctor who treated her. We only found out about this adverse effect when we called her to schedule her 2nd dose.